Impact of response shift on longitudinal quality-of-life assessment in cancer clinical trials.
about
Efficacy, safety, and survival with ruxolitinib in patients with myelofibrosis: results of a median 3-year follow-up of COMFORT-I.Characterizing fatigue associated with sunitinib and its impact on health-related quality of life in patients with metastatic renal cell carcinomaQuality of life after cancer-How the extent of impairment is influenced by patient characteristics.An item-level response shift study on the change of health state with the rating of asthma-specific quality of life: a report from the PROMIS(®) Pediatric Asthma StudyImpact of the occurrence of a response shift on the determination of the minimal important difference in a health-related quality of life score over time.Health-related quality of life in patients with brain tumors: limitations and additional outcome measures.How health-related quality of life assessment should be used in advanced colorectal cancer clinical trials.Quality of life after mastectomy with or without immediate breast reconstruction.Patient-physician communication and health-related quality of life of patients with localised prostate cancer undergoing radical prostatectomy - a longitudinal multilevel analysis.A pilot randomized trial to prevent sexual dysfunction in postmenopausal breast cancer survivors starting adjuvant aromatase inhibitor therapy.Needs and priorities of women with endometrial and cervical cancer.Does the site of anastomosis for esophagectomy affect long-term quality of life?Predictors of satisfaction with treatment decision, decision-making preferences, and main treatment goals in patients with advanced cancer.Associations between self-rated health, sickness behaviour and inflammatory markers in primary care patients with allergic asthma: a longitudinal study.
P2860
Q33419957-359517F0-5323-4596-A657-78F0321C1677Q34507381-0E2F7E5B-B0A0-4ADE-9561-E3B223B50ABCQ36159779-EA921A5B-61AE-48E0-8968-F74C586F0778Q36913672-AD31AE0C-F832-4CB6-929A-DF36A8B28C06Q37470535-2937954A-9BF7-4545-B3EF-40BE08308AC8Q38105945-4A873E03-254B-4CFD-AA1A-09EC3E43F9CEQ38826639-341545BF-D374-4C20-ACE2-481A3EEBA642Q38841115-77219971-DA97-4DB2-8103-E0F24298E233Q38886996-C086B4A3-2871-42F1-AB1A-FDEA293DD01AQ38947105-29044558-1685-4A2D-9792-6F2FA66DD1B4Q40784769-8D845097-9927-487B-8448-33FCD5C789BDQ41682289-519EF528-7B74-4108-A107-1406231F2953Q42607439-611A9AB1-C039-41A6-BED4-ACB9F3E3A1E7Q47141809-05D98BAA-90D4-49EC-AAA7-A65E0DC50BE7
P2860
Impact of response shift on longitudinal quality-of-life assessment in cancer clinical trials.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Impact of response shift on lo ...... ent in cancer clinical trials.
@en
Impact of response shift on lo ...... ent in cancer clinical trials.
@nl
type
label
Impact of response shift on lo ...... ent in cancer clinical trials.
@en
Impact of response shift on lo ...... ent in cancer clinical trials.
@nl
prefLabel
Impact of response shift on lo ...... ent in cancer clinical trials.
@en
Impact of response shift on lo ...... ent in cancer clinical trials.
@nl
P2093
P2860
P356
P1476
Impact of response shift on lo ...... ent in cancer clinical trials.
@en
P2093
Franck Bonnetain
Tienhan Sandrine Dabakuyo
Zeinab Hamidou
P2860
P304
P356
10.1586/ERP.11.57
P577
2011-10-01T00:00:00Z